Guardant Health Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Welcome, everybody. I'm Matt Sykes, Senior Life Sciences Tools and Diagnostics Analyst at Goldman Sachs. And today, I have the pleasure of having Helmy Eltoukhy and Mike Bell from Guardant -- Helmy's Chief Executive Officer and Founder; and Mike Bell is the Chief Financial Officer. Thank you both for joining us. I appreciate your time today.
Yes, thanks for having us.
No problem. I thought maybe we'd start out and kind of let you set the stage a little bit, maybe talk about some of the recent results, kind of your view on the year and some of the key drivers for investors to look for?
Yes. No, thank you. 2021 is really, I think, a fantastic year for Guardant.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
